Back to discover
Disease
Otorhinolaryngologic Diseases
Active therapeutic pipelineEmerging research
1
Publications
6
Clinical trials
2025
Latest publication
Latest activity
betaRecent clinical, regulatory, research and industry developments relating to this disease.
Otolaryngologic Side Effects of GLP-1 Receptor Agonists.
Research2025-02-12The Laryngoscope
What's happening now
An analyst briefing on current research, clinical, regulatory and industry activity surrounding this disease.
Executive briefingUpdating summary…Momentum: Low
Key developments
- 1 clinical trial with recent milestones.
Major developments
Major clinical milestoneWorth watching
Primary completion2025-12-16
Clinical MilestonesViewHide
Recently completed
Activity timeline1
Clinical trials
The current development programme across all trial phases.
Clinical programme
6
1
0
3
Recently completed
Research activity
Key research shaping understanding of this disease, combining the latest publications with the most influential evidence.
Most influential
Recent publications
Major themes3
- Glucagon-Like Peptide-1 Receptor Agonists1
- Hypoglycemic Agents1
- Otorhinolaryngologic Diseases1
Leading journals1
- The Laryngoscope1
Leading researchers8
- Ahmed OG1
- Dhanda A1
- Dongre R1
- Khan FI1
- Khan N1
- Mehdi Z1
- Rashidi K1
- Razmi S1
Affiliations (unnormalised)2
- Houston Methodist Hospital1
- Texas A&M School of Engineering Medicine1
Reference
Authoritative identity, definition & identifiers.
Defined in MeSH
Pathological processes of the ear, the nose, and the throat, also known as the ENT diseases.
Identifiers
References & data sources
- Disease identity & definition — NLM Medical Subject Headings (MeSH), public domain
- Clinical trials — ClinicalTrials.gov (U.S. National Library of Medicine)
- Research activity — Europe PMC (EMBL-EBI) + OpenAlex-derived paper links
- Related entities are derived from literature co-mention (studied together) — associative, not causal.